Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5381_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
09.09.2026
Размер:
17 Мб
Скачать
8.3 Medical significance of Rauwolfia 115
https://t.me/med1917
8.2.3 Rauwolfia serpentina (L.) Benth. ex. Kurz.
R. serpentina (L.) Benth. ex. Kurz. is an under shrub, belongs to Apocynaceae fam­ily of dicotyledonous. It is indigenous to India and other tropical countries of Asia and is naturalized in distribution. Typical morphological characteristics of the plant include small in appearance, completely erect in size with presence of glabrous shrub, whe re the approximate height includes 30e60 cm. Also the presence of whorled type leaves possess length 7.5e17.5 cm, with lanceolate or oblanceolate appearance in shape, acute or acuminate aperture, along with characteristic tapering at the petiole. Moreover, the plant bears flowers with white to pinkish appearance, peduncles of 5.0e7.5 cm in length, pedicels and calyx red, with calyx lobes of
2.5 mm long and lanceolate. The roots of the plants are 5e15 cm long and 3e20 mm in diameter, subcylindrical to tapered structure. Moreover, the plants include tortuous or curved shaped structure, rarely branched appearance, occasion­ally bearing twisted rootlets. Moreover, the external appearance of the plant indi­cates light brown to grayish yellow and grayish brown color.
8.3 Medical significance of Rauwolfia
Plants are utilized therapeutically in different countries and are a source of numerous potent and powerful drugs. Medicinal plants are used by 80% of the world’s popu­lation as the main accessible medicines especially in developing nations. Rauwolfia can be regarded as a typical drug of ayurvedic medicaments.
R. serpentina has a broad range of therapeutic spectrum, mainly effective in the treatment of hypertension and psychotic disorders like schizophr enia, anxiety, epi­lepsy, insomnia, insanity, and furthermore, utilized as a sedative, a hypnotic drug. Rauwolfia has been studied widely in researches as a treatment for autistic children between the ages of 3.5 and 9 years (Lehman et al., 1957).
The plant is accounted for a large number of therapeutically useful indole alka­loids and these alkaloids are extensively situated in the roots. Alkaloids of this plant have a great therapeutic significance to treat cardiovascular diseases, hypertension (Silja et al., 2008), arrhythmia, breast cancer, and human promyelocytic leukemia (Itoh et al., 2005).
The Rauwolfia root has been consumed since the pre-Vedic period as a medica­tion in India, to treat snake bites and fever and bug stings (Thakar, 2010). Its roots are utilized as an esteemed medicine for blood pressure, insomnia anxiety, excite­ment, schizophrenia, insanity, epilepsy, hypochondria, and other disorders of the central nervous system (Singh et al., 2010; Agrawal and Mishra, 2013).
The root was believed to stimulate uterine contraction and suggested for the use in childbirth. However, the juice of the leaves has been used as a remedy for the opacity of the cornea. Rauwolfia’s juice and extract acquired from the root can be used for treating gastrointestinal and circulatory illnesses. The juice of tender leaves and root extracts are used to treat liver pain, stomach pain, dysentery, and to elim­inate intestinal worms.
116 CHAPTER 8 Rauwolfia serpentina
https://t.me/med1917
The extract is likewise utilized to treat cancer which is one of the leading causes of death. Plant extract has been reported to use in treatment of prostate cancer and AIDS (Dey and De, 2011). Extracts from the root and bark of the plant are enriched with compounds of b-carboline alkaloid family of which the main constituent is alstonine. This compound has been reported to reduce tumor cell growth in mice inoculated with YC8 lymphoma cells or Ehrlich ascetic cells. The plant extract has antiprostate cancer activity in both in vitro and in vivo model systems which, based upon analyses of gene expression patterns of treated prostate cancer cells, may be modulated by its effects on DNA damage and cell cycle control signaling pathways.
8.4 Phytochemical constituents of Rauwolfia
The phytochemical analysis of R. serpentina has numerous medicinal values. Alka­loids are huge cluster of phytochemicals which contain a heterocyclic nitrogen ring. Till date, over 6000 basic nitrogen containing organic compounds have been isolated, which are now classified under different categories of alkaloids. Out of this huge num­ber, around 15% of compounds have been isolated from vascular terrestrial plants of 150 different families. The pure alkaloids are used as analgesic, antispasmodic, and bactericidal effects (Okwu and Okwu, 2004). The medicinal value of plants lies in the bioactive phytochemical constituents that produce definite physiological effects on human body. These natural compounds formed the base of modern drugs as we use today (Koche et al., 2010). Herbal medicines are becoming popular in modern world as people resort to natural therapies. Natural products isolated from higher plants and microorganisms have been providing novel clinically active drugs (Nirai-
mathi et al., 2012). The plant contains more than 70 distinct alkaloids which belong
to the monoterpenoid indole alkaloid (MIA) family. The major alkaloids are reserpine, ajmaline, ajmalicine, ajmalimine, deserpidine, indobine, indobinine, reserpiline, rescinnamine, rescinnamidine, serpentine, serpentinine, and yohimbine (Howes and
Louis, 1990; Srivastava et al., 2006). Chemical structures of major alkaloids present
in R. serpentina are presented in Fig. 8.1. Different types of alkaloids in R. serpentina along with their physical and medicinal properties are given in Tab l e 8.2 .
8.4.1 Reserpine
Reserpine is a pure crystalline single alkaloid. It is a white-to-yellow powder that becomes darker when exposed to light. It is odorless, insoluble in water, slightly sol­uble in alc ohol, and freely soluble in acetic acid. It has a chemical formula of C
33H40N2O9
trimethyl benzoic acid ester of reserpic acid, an indole derivative of 18-hydroxy yohimbine type) is used in hypersensitive reactions and also act as natural tranquil­lizer (Banerjee and Modi, 2010). Reserpine can be used in the antihypertensive ac­tions by act on peripheral nervous system by binding to catecholamine storage
, a molecular mass of 609 g, and a bitter taste. Reserpine (3,4,5-
8.4 Phytochemical constituents of Rauwolfia 117
https://t.me/med1917
FIGURE 8.1
Chemical structures of some alkaloids present in Rauwolfia serpentina.
vesicles present in the nerve cell (Ellenhorn and Barceloux, 1988; Gilman et al.,
1990). It is useful for the treatment of hypertension, cardiovascular diseases, and
neurological diseases (Weiss and Fintelmann, 2000; Pullaiah, 2002).
The mechanism of action of reserpine is well researched and well documented. Reserpine binds to protein receptors called vesicular monoamine transporters (VMATs) in the organelle membranes of specialized secretory vesicles of presynap­tic neurons. Reserpine prevents intracellular neurotransmitters from binding to VMAT proteins and stops secretory vesicles from uptaking neurotransmitters. Ulti­mately, use of reserpine provides that no or few neurotransmitters are released from the presynaptic neuron (Nammi et al., 2005). As a result, no or only slight promul­gation of the nerve impulse occurs in the postsynaptic neuron.
8.4.2 Biosynthesis of reserpine
Alkaloids have a strong geneticephysiological function and background in the or­ganisms which produce them. The biogenesis of alkaloids is therefore a part of the total geneticefunctional strategy of such metabolisms. In the genus Rauwolfia, MIAs are formed via complex biosynthetic sequences. The characteristics of R. serpentina are only the most prominent representatives of the aforementioned class of specialized metabolites, collectively forming several hundred different MIA structures within the plant genera. MIAs are medicinally important class of compounds abundant in the roots of Rauwolfia species (Apocynaceae). MIAs have the pentacyclic ring system consisting of monoterpene and indole moieties which are biologically derived from secologanin and tryptophan, respectively. MIAs are widespread within the Apocynaceae, underscoring the importance of numerous members of the botanical family as sources of high-value compounds boasting pharmacological potential.
Table 8.2 Phytochemicals constituents of Rauwolfia and their medicinal properties.
https://t.me/med1917
Alkaloids
Reserpine C
Ajmaline C
Rescinnamine C
Serpentine C
Deserpidine C
Yohimbine C
Ajmalicine C
Molecular formula Nature Functions
33H40N2O9
Indole alkaloid, soluble in
Antipsychotic, antihypertensive
chloroform
20H26N2O2
Alkaloid, miscible in
Antiarrhythmic 158C Indole alkaloids antiarrhythmics
water
35H42N2O9
Weakly basic indole
Antihypertensive 238C Alkaloid angiotensin converting
alkaloids
20H21N2O3
Basic anhydronium
Tranquilizer 153C Type II topoisomerase inhibitor Dassonneville
alkaloids
32H38N2O8
Ester alkaloid Antipsychotic
and antihypertensive
21H26N2O3
Indoloquinolizidine alkaloid
Selective alpha­adrenergic antagonist, aphrodisiac
21H24N2O3
Indoline alkaloids Vasodilator 250C Vasodilator agent,
Melting point Category of drug References
264.5C Indole alkaloids antihypertensive agent, adrenergic uptake inhibitor, antipsychotic agent, hypotensive agent, membrane transport modulator, neurotransmitter agent (OCT2 substrates)
(class I and III), cardiovascular system, membrane transport modulators, secologanin tryptamine alkaloids, sodium channel blocker, voltage-gated sodium channel blocker
enzyme inhibitor cardiovascular system
230.5C Inhibitor of the ATP/Mg pump
241C Treatment of erectile
dysfunction
antihypertensive agent
118 CHAPTER 8 Rauwolfia serpentina
Weiss and Finelman (2000), Pullaiah (2002), Nammi et al. (2005), Banerjee and Modi (2010)
Brugada et al. (2003)
Kolh et al. (1954)
2þ
et al. (1999) Varchi et al.
(2005)
Morales (2000)
Wink and Roberts (1998)
8.4 Phytochemical constituents of Rauwolfia 119
https://t.me/med1917
The shikimate pathway consists of a sequence of seven metabolic steps, in which phosphoenolpyruvate and erythrose 4-phosphate are converted to chorismate, the precursor of the aromatic amino acids and many aromatic secondary metabolites. Tryptophan decarboxylase catalyzes the conversion of Common to the biosynthesis of all MIAs is the formation of their terpenoid precur­sor, secologanin intermediate of MEP pathway (Stockigt and Zenk, 1977). Its sub­sequent ligation to tryptamine yields the universal intermediate, Strictosidine. There are different alkaloids produced due to enzyme strictosidine synthase (STR) in R. serpentina, mainly the indole alkaloids are shown in Fig. 8.2. The gener al role played by intermediate strictosidine in the biosynthesis of all MIAs is firmly estab­lished (Kutchan et al., 1988; Bracher and Kutchan, 1992).
Shikimatic pathway MEP Pathway
L-tryptophan to L-tryptamine.
Reserpine
1,2-
b-(R)-Dihydrovomilenine
DHVR
Tryptamine +
Strictosidine
Vomilenine
VR
17-O-Acetylnorajmaline
Ajmalicine
Secologanin
Strictosidine synthase (STR)
VR2
19,20-
a-(S)-dihydrovomilenine
AAE
Strictosidine aglycoside
SDG
4,21-dehydrogeissoschizine
Cathenamine
Yohimbine
FIGURE 8.2
Enzyme-catalyzed biosynthesis of reserpine alkaloids via strictosidine intermediate.
Peroxidase
Serpentine
120 CHAPTER 8 Rauwolfia serpentina
https://t.me/med1917
8.4.3 Biosynthesis of strictosidine
The biological material can be the key to successfully investigate a biosynthetic pathway at the molecular level. This is especially true for pathways operating in higher plants due to their slow growth characteristics. This “upstream pathway” was elucidated in detail on enzymatic and genetic level (Geu-Flores et al., 2012;
Asada et al., 2013; Salim et al., 2013, 2014; Miettinen et al., 2014). However, the
manifold reactions, spearheaded by deglucosylation of strictosidine, providing the abundance of MIA carbon skeletons, are still elusive. Further, of the various “down­stream pathways” leading to the pharmacologically important structures, only a few are known. This condensation is catalyzed by the enzyme STR (Treimer and Zenk,
1979) through a stereoselective PicteteSpengler reaction mechanism in order to
yield a b-carboline product (Mar esh et al., 2008). Strictosidine b-glucosidase (Lui-
jendijk et al., 1998) cleaves the glucose moiety of strictosidine to produce an unsta-
ble aglycone molecule which spontaneously leads to the formation of a series of reactive intermediates that serve as starting materials for the biosynthesis of different MIA backbones/groups.
8.4.4 Ajmaline
Ajmaline is a class I antiarrhythmic agent, it is highly useful in diagnosing Brugada syndrome (hereditary card iac disorder) (Brugada et al., 2003), and differentiating between subtypes of patients with this disease (Paul et al., 2003). These agents are primarily classified into four major groups on the basis of their mechanism of action, i.e., sodium channel blockade, beta-adrenergic blockade, repolarization pro­longation, and calcium channel blockade. Ajmaline is a sodium channel blocker that shows instant action when given intravenously, which makes it ideal for diagnostic purposes (Dobbels et al., 2016). It has been reported to stimulate respiration and in­testinal movements. The action of ajmaline on systemic and pulmonary blood pres­sure is similar as of serpentine.
8.4.5 Biosynthesis of ajmaline
Simplified pathway leading from strictosidine via vomilenine to ajmaline. Two routes from vomilenine to 17-O-acetylnorajmaline can be postulated, depending on which of the two double bonds is reduced, first: reduction of the indolenine ring in 1,2-position (VR) followed by reduction of the 19,20-double bond (DHVR), as proposed by Gao et al. (2002) and von Schumann et al. (2002). The next step along the ajmaline biosynthetic pathway involves hydrolysis of the 17­O-acetylated norajmaline by the enzyme acetylajmalan esterase (AAE). The last step involves an S-adenosyl-
et al., 1983) which catalyzes the indoline nitrogen methylation of norajmaline to
produce ajmaline.
L-methionineedependent methyltransferase (Sto
ckigt
¨
8.5 Omics strategies and advancements 121
https://t.me/med1917
8.4.6 Biosynthesis of serpentine
Serpentine are indole alkaloids of considerable medicinal importance. Serpentine is an inhibitor of topoisomerase (Type II) as well as antipsychotic properties (Dasson-
neville et al., 1999; Santos et al., 2017). In vacuole, an enzyme (PER) peroxidase is
responsible for oxidation of ajmali cine to serpentine (O’Connor and Maresh, 2006).
8.4.7 Biosynthesis of yohimbine
Yohimbine is an indoloquinolizidine alkaloid, used as a selective alpha-adrenergic antagonist or alpha-blocker in the blood vessels for the treat ment of erectile dysfunc­tion in man (Goldberg and Robertson, 1983; Morales, 2000). Its action on peripheral blood vessels is weaker as compared to reserpine. Yohimbine has a mild antidiuretic action, probably via stimulation of hypothalmic center and release of posterior pitu­itary hormone. Antagonism at these receptors relaxes smooth muscle and lowers blood pressure.
Biosynthetic pathway of Yohimbine is involved homoallylic isomerization of the keto dehydrogeissoschizine followed by 1,4 conjugate addition. However, detailed mechanism of biosynthetic route of Yohimbine is yet to be identified due to uniden­tification of enzymes in deglycosylated strictosidine.
8.5 Omics strategies and advancements
Plants are a rich source of assorted specialized metabolites that have been utilized for thousands of years as scents, flavoring agents, pigments, insect repellents, and therapeutic compounds (Facchini et al., 2012). These secondary metabolites are considered to be the fundamental approach used by plants to acclimate and persist in various ecological niches and environmental conditions and to tackle biotic as well as abiotic intrusions in their natural habitat (Furstenberg-Hagg et al., 2013;
Weng, 2014).
The specialized plant secondary metabolites are characterized by complex chem­ical structures which are derived from simpler precursors, suggesting the involve­ment of complicated biosynthetic machinery and regulatory processes that have been strongly favored and developed via natural selection (Moore et al., 2014).
Therefore, mapping plant genes to a biosynthetic pathway necessitates the tedious and time-consuming experimental approach of figuring out one gene at a time. Such identification becomes even more challenging due to genetic redundancy and tight genetic regulation; therefore, to confirm or verify the function of a plant gene, multiple lines of evidence are required. Since secondary metabolic pathways and their regulation include extremely complex frameworks with interconnected components, studies comprising association-based analysis within multiple ele­ments can serve as an important alternate for plant-derived metabolic pathway dis­covery (Steuer, 2007; Sweetlove et al., 2008; Tomar and De, 2013).
122 CHAPTER 8 Rauwolfia serpentina
https://t.me/med1917
In recent years, “Omics”-based strategies have gained a great deal of popularity among plant biologists and research community as an approach for functional char­acterization of target plant genes and to investigate systems response under specific conditions (Muranaka and Saito, 2013; Saito, 2013; Wurtzel and Kutchan, 2016). Qualitative and quantitative analysis of various elements of a biological system, such as specialized metabolites, transcript expression, and protein levels while capturing the spatiotemporal responses, provides imperative insights into various ongoing processes and interactions/associations within them. While each omics datasets gives a broad overview of the static or dynamic condition of a biological system, the integration of various datasets provides an effective and efficient means to strengthen genuine observations and reduces the probability of false positives/ negatives (Moreno-Risueno et al., 2010; Deshmukh et al., 2014; Rai et al., 2016). The representation of different omics approaches and strategies used in R. serpentina has been depicted in Fig. 8.3.
8.5.1 Genomic technologies and genetic markers
Whole-genome sequences serves as an imperative resource for understanding the to­tal biosynthetic potential of a medicinal plant. It also facilitates the development of herbal medicines and selection of cultivars with desired agricultural traits and high levels of secondary metabolites having pharmaceutical and medicinal importance (Hao and Xiao, 2015; Unamba et al., 2015). Total reliance on medicinal plan ts for extraction of essential bioactive compounds has proved to be an impractical and un­sustainable approach (Chang and Keasling, 2006; Facchini et al., 2012); therefore,
FIGURE 8.3
The representation of different omics approaches and strategies used in Rauwolfia serpentina.
8.5 Omics strategies and advancements 123
https://t.me/med1917
knowledge and understanding of biosynthetic pathway components offers an oppor­tunity to develop alternate sources for obtaining these important compounds.
Genomic sequences give vital information on plant origin and evolution, inherit­able characters, physiological and developmental schematics, epigenetic regulation, and metabolic potential, which serves as the basis for interpreting genetic as well as chemodiversity at the molecular level (Dhanapal and Govindaraj, 2015; Hao and
Xiao, 2015; Unamba et al., 2015).
Genomic sequences helps in the development of easily available and robust func­tional genomic resources, like full-length complementary DNA (cDNA) clones, tagged mutant lines, and facile and rapid transformation method. It also provides essential information on multiple homologous genes of specialized biosynthetic pathways, thereby improving capability and possibilities to carry out gene knockout experiments to decipher their functionality.
Elucidation of the MIA biosynthesis has recently advanced in Apocynaceae fam­ily through simultaneous development of transcriptomic resource analyses and reverse genetics strategies achieved by means of virus-induced gene silencing (VIGS). Most of these tools have been basically adapted for Catharanthus roseus; however, the VIGS technique has been barely used on other Apocynaceae species. Rauwolfia species not only constitutes a significant source of explicit and valuable secondary metabolites such as reserpine, ajmaline, ajmalicine, etc., but are also well-established models for understanding alkaloid metabolism, and as such would certainly benefit from an effective VIGS procedure. It has been demonstrated that biolistic-mediated VIGS technique can be efficiently used for gene silencing in both R. serpentina and R. tetraphylla taking advantage of a recently modified inoc­ulation method in tobacco rattle virus (TRV) vectors via particle bombardment (Cor-
bin et al., 2017). TRV vectors, namely pTRV1 and pTRV2-MCS encoding the two
genomic components of TRV obtained from Arabidopsis Biological Resource Centre (http://www.arabidopsis.org), were used to generate silencing constructs and for propagating the virus within Rauwolfia plantlets. After standardizing bombardment conditions while minimizing transformed plantlet injury, gene down­regulation was observed with an approximately 70% decr ease in expression by silencing phytoene desaturase gene in both Rauwolfia species. This established gene silencing methodology will thus contribute as a valuable tool in identification and characterization of alkaloid biosynthesis genes in these prevalent Rauwolfia spe­cies as well as other closely related medicinal plant species.
DNA-based molecular markers have been widely utilized in recent years for assessment of genetic diversity among the germplasm in various medicinal plant species. Nair et al. (2014) investigated genetic diversity in populations of R. serpentina based on random amplified polymorphic DNA (RAPD) marker s. Within population a high genetic diversity and among population high genetic dif­ferentiation was revealed which was suggested to be caused both by habitat frag­mentation of the lower size populations as well as the low gene flow level among them. The findings of this study showed that RAPD-based assessment of genetic di­versity in R. serpentina seemed to be adequately informative and powerful. The
124 CHAPTER 8 Rauwolfia serpentina
https://t.me/med1917
information on genetic diversity and structure among populations of R. serpentina would be helpful in developing appropriate conservation strategies and breeding programs.
Comparative genomics has been described as one of the most effective and suc­cessful methods for characterization of gene functions, identification of biomarkers, and investigation of evolutionary relatedness in humans (Moreno et al., 2008)as well as plants (Moreno et al., 2008; Michael and Jackson, 2013). Pathania et al.
(2016) carried out comparative co-expression analysis of R. serpentina and
C. roseus which revealed evolutionary complexity in secondary metabolism. Comparative analysis approach is instigated for comparing two or more organisms in order to identify similarities among them as well as to investigate mechanisms responsible for diversification in various key biological phenomena such as photo­synthesis, reproduction and defense response, metabolic pathways, and many more. The basis of comparative analysis is that biologically significant processes remain conserved across different organisms in comparison to nonrelevant associa­tions which decline with evolutionary time scale (Hansen et al., 2014). Comparative co-expression analysis technique can be used to determine genes playing role in dif­ferential tissue-specific and species-specific biosynthesis of metabolites. High­throughput expression data availability and the use of computational analysis approach for integration of expression data prompted to determine candidate genes/biomarkers involved in variation of MIAs between R. serpentina and C. roseus. Network-based approach was used to carry out differential expression analysis for identification of candidate genes accountable for species-specific pro­duction of metabolites in these medicinal plants. The key genes of MIA biosynthesis contributing toward diversification of metabolites have been identified using this approach.
Gene expression is considered as an intricate phenomenon being regulated by a set of proteins known as transcription factors (TFs), which are responsible for acti­vating or repressing various genes (Mitsuda and Ohme-Takagi, 2009). This gene regulation by TFs takes place via a set of highly synchronized internal and/or external signals. Some TFs also interact with one another to regulate genes (Yang
et al., 2012). Identification of TFs regulating secondary metabolism in
R. serpentina has been carried out by Pathania and Acharya (2016). Unraveling the interaction between genes and various TFs is essential for gaining complete un­derstanding and knowledge of secondary metabolism in plants. It is necessary to identify transcriptional regulators along with their targets (genes) involved in sec­ondary metabolites bios ynthesis, to gain in-depth insights of metabolic pathways associated with them. The authors employed an integrative appro ach using omics data in order to identify TFs with unknown functionality and illustrated their roles in regulating valuable metabolites along with metabolic traits. Identification of TFs functionality was carried out by implementin g gene co-expression network analysis, which could not have been possible to annotate using any other simple methods. The TF families, WRKY and AP2-EREBP, were identified to be playing regulatory roles in regulating alkaloids biosynthesis in R. serpentina. TFs regulating